GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$132.60
Tradestie Score
55
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
-1.0%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$194.28
|
$8.57B | - | 58 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$344.87
|
$8.39B | - | 33 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$166.66
|
$7.81B | - | 61 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$68.41
|
$6.00B | - | 73 | Compare |
|
BLLN
BLLN
|
$104.67
|
$4.88B | 164.3 | 49 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.77
|
$4.60B | 31.5 | 63 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$68.94
|
$3.26B | - | 77 | Compare |
|
VCYT
Veracyte, Inc.
|
$46.22
|
$2.85B | 32.0 | 50 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.33
|
$2.22B | - | 66 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$149.13
|
$1.77B | - | 58 | Compare |
More GRAL Analysis
Data updated: Oct 21, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry